Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial
Melatonin may benefit diabetic people with coronary heart disease (CHD) through its beneficial effects on biomarkers of oxidative stress and cardio-metabolic risk. This investigation evaluated the effects of melatonin administration on metabolic status in diabetic patients with CHD.
Autor*in: |
Raygan, Fariba [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2019 |
---|
Schlagwörter: |
---|
Umfang: |
6 |
---|
Übergeordnetes Werk: |
Enthalten in: Tip Avalanche Photodiode—A spherical-junction SiPM concept - Vinogradov, S. ELSEVIER, 2022, the official journal of the European Society of Parenteral & Enteral Nutrition, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:38 ; year:2019 ; number:1 ; pages:191-196 ; extent:6 |
Links: |
---|
DOI / URN: |
10.1016/j.clnu.2017.12.004 |
---|
Katalog-ID: |
ELV045705380 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV045705380 | ||
003 | DE-627 | ||
005 | 20230624115848.0 | ||
007 | cr uuu---uuuuu | ||
008 | 191021s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.clnu.2017.12.004 |2 doi | |
028 | 5 | 2 | |a GBV00000000000523.pica |
035 | |a (DE-627)ELV045705380 | ||
035 | |a (ELSEVIER)S0261-5614(17)31424-3 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 530 |q VZ |
084 | |a 33.05 |2 bkl | ||
084 | |a 33.07 |2 bkl | ||
084 | |a 33.40 |2 bkl | ||
100 | 1 | |a Raygan, Fariba |e verfasserin |4 aut | |
245 | 1 | 0 | |a Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
264 | 1 | |c 2019 | |
300 | |a 6 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a Melatonin may benefit diabetic people with coronary heart disease (CHD) through its beneficial effects on biomarkers of oxidative stress and cardio-metabolic risk. This investigation evaluated the effects of melatonin administration on metabolic status in diabetic patients with CHD. | ||
650 | 7 | |a Oxidative stress |2 Elsevier | |
650 | 7 | |a Melatonin supplementation |2 Elsevier | |
650 | 7 | |a Metabolic status |2 Elsevier | |
650 | 7 | |a Inflammation |2 Elsevier | |
650 | 7 | |a Type 2 diabetes mellitus |2 Elsevier | |
650 | 7 | |a Coronary heart disease |2 Elsevier | |
700 | 1 | |a Ostadmohammadi, Vahidreza |4 oth | |
700 | 1 | |a Bahmani, Fereshteh |4 oth | |
700 | 1 | |a Reiter, Russel J. |4 oth | |
700 | 1 | |a Asemi, Zatollah |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier |a Vinogradov, S. ELSEVIER |t Tip Avalanche Photodiode—A spherical-junction SiPM concept |d 2022 |d the official journal of the European Society of Parenteral & Enteral Nutrition |g Amsterdam [u.a.] |w (DE-627)ELV008775001 |
773 | 1 | 8 | |g volume:38 |g year:2019 |g number:1 |g pages:191-196 |g extent:6 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.clnu.2017.12.004 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
936 | b | k | |a 33.05 |j Experimentalphysik |q VZ |
936 | b | k | |a 33.07 |j Spektroskopie |q VZ |
936 | b | k | |a 33.40 |j Kernphysik |q VZ |
951 | |a AR | ||
952 | |d 38 |j 2019 |e 1 |h 191-196 |g 6 |
author_variant |
f r fr |
---|---|
matchkey_str |
rayganfaribaostadmohammadivahidrezabahma:2019----:eaoiamnsrtolwrboakrooiaietesncrimtblciknyedaeiptetwtcrnrhatiesa |
hierarchy_sort_str |
2019 |
bklnumber |
33.05 33.07 33.40 |
publishDate |
2019 |
allfields |
10.1016/j.clnu.2017.12.004 doi GBV00000000000523.pica (DE-627)ELV045705380 (ELSEVIER)S0261-5614(17)31424-3 DE-627 ger DE-627 rakwb eng 530 VZ 33.05 bkl 33.07 bkl 33.40 bkl Raygan, Fariba verfasserin aut Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial 2019 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Melatonin may benefit diabetic people with coronary heart disease (CHD) through its beneficial effects on biomarkers of oxidative stress and cardio-metabolic risk. This investigation evaluated the effects of melatonin administration on metabolic status in diabetic patients with CHD. Oxidative stress Elsevier Melatonin supplementation Elsevier Metabolic status Elsevier Inflammation Elsevier Type 2 diabetes mellitus Elsevier Coronary heart disease Elsevier Ostadmohammadi, Vahidreza oth Bahmani, Fereshteh oth Reiter, Russel J. oth Asemi, Zatollah oth Enthalten in Elsevier Vinogradov, S. ELSEVIER Tip Avalanche Photodiode—A spherical-junction SiPM concept 2022 the official journal of the European Society of Parenteral & Enteral Nutrition Amsterdam [u.a.] (DE-627)ELV008775001 volume:38 year:2019 number:1 pages:191-196 extent:6 https://doi.org/10.1016/j.clnu.2017.12.004 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 33.05 Experimentalphysik VZ 33.07 Spektroskopie VZ 33.40 Kernphysik VZ AR 38 2019 1 191-196 6 |
spelling |
10.1016/j.clnu.2017.12.004 doi GBV00000000000523.pica (DE-627)ELV045705380 (ELSEVIER)S0261-5614(17)31424-3 DE-627 ger DE-627 rakwb eng 530 VZ 33.05 bkl 33.07 bkl 33.40 bkl Raygan, Fariba verfasserin aut Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial 2019 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Melatonin may benefit diabetic people with coronary heart disease (CHD) through its beneficial effects on biomarkers of oxidative stress and cardio-metabolic risk. This investigation evaluated the effects of melatonin administration on metabolic status in diabetic patients with CHD. Oxidative stress Elsevier Melatonin supplementation Elsevier Metabolic status Elsevier Inflammation Elsevier Type 2 diabetes mellitus Elsevier Coronary heart disease Elsevier Ostadmohammadi, Vahidreza oth Bahmani, Fereshteh oth Reiter, Russel J. oth Asemi, Zatollah oth Enthalten in Elsevier Vinogradov, S. ELSEVIER Tip Avalanche Photodiode—A spherical-junction SiPM concept 2022 the official journal of the European Society of Parenteral & Enteral Nutrition Amsterdam [u.a.] (DE-627)ELV008775001 volume:38 year:2019 number:1 pages:191-196 extent:6 https://doi.org/10.1016/j.clnu.2017.12.004 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 33.05 Experimentalphysik VZ 33.07 Spektroskopie VZ 33.40 Kernphysik VZ AR 38 2019 1 191-196 6 |
allfields_unstemmed |
10.1016/j.clnu.2017.12.004 doi GBV00000000000523.pica (DE-627)ELV045705380 (ELSEVIER)S0261-5614(17)31424-3 DE-627 ger DE-627 rakwb eng 530 VZ 33.05 bkl 33.07 bkl 33.40 bkl Raygan, Fariba verfasserin aut Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial 2019 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Melatonin may benefit diabetic people with coronary heart disease (CHD) through its beneficial effects on biomarkers of oxidative stress and cardio-metabolic risk. This investigation evaluated the effects of melatonin administration on metabolic status in diabetic patients with CHD. Oxidative stress Elsevier Melatonin supplementation Elsevier Metabolic status Elsevier Inflammation Elsevier Type 2 diabetes mellitus Elsevier Coronary heart disease Elsevier Ostadmohammadi, Vahidreza oth Bahmani, Fereshteh oth Reiter, Russel J. oth Asemi, Zatollah oth Enthalten in Elsevier Vinogradov, S. ELSEVIER Tip Avalanche Photodiode—A spherical-junction SiPM concept 2022 the official journal of the European Society of Parenteral & Enteral Nutrition Amsterdam [u.a.] (DE-627)ELV008775001 volume:38 year:2019 number:1 pages:191-196 extent:6 https://doi.org/10.1016/j.clnu.2017.12.004 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 33.05 Experimentalphysik VZ 33.07 Spektroskopie VZ 33.40 Kernphysik VZ AR 38 2019 1 191-196 6 |
allfieldsGer |
10.1016/j.clnu.2017.12.004 doi GBV00000000000523.pica (DE-627)ELV045705380 (ELSEVIER)S0261-5614(17)31424-3 DE-627 ger DE-627 rakwb eng 530 VZ 33.05 bkl 33.07 bkl 33.40 bkl Raygan, Fariba verfasserin aut Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial 2019 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Melatonin may benefit diabetic people with coronary heart disease (CHD) through its beneficial effects on biomarkers of oxidative stress and cardio-metabolic risk. This investigation evaluated the effects of melatonin administration on metabolic status in diabetic patients with CHD. Oxidative stress Elsevier Melatonin supplementation Elsevier Metabolic status Elsevier Inflammation Elsevier Type 2 diabetes mellitus Elsevier Coronary heart disease Elsevier Ostadmohammadi, Vahidreza oth Bahmani, Fereshteh oth Reiter, Russel J. oth Asemi, Zatollah oth Enthalten in Elsevier Vinogradov, S. ELSEVIER Tip Avalanche Photodiode—A spherical-junction SiPM concept 2022 the official journal of the European Society of Parenteral & Enteral Nutrition Amsterdam [u.a.] (DE-627)ELV008775001 volume:38 year:2019 number:1 pages:191-196 extent:6 https://doi.org/10.1016/j.clnu.2017.12.004 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 33.05 Experimentalphysik VZ 33.07 Spektroskopie VZ 33.40 Kernphysik VZ AR 38 2019 1 191-196 6 |
allfieldsSound |
10.1016/j.clnu.2017.12.004 doi GBV00000000000523.pica (DE-627)ELV045705380 (ELSEVIER)S0261-5614(17)31424-3 DE-627 ger DE-627 rakwb eng 530 VZ 33.05 bkl 33.07 bkl 33.40 bkl Raygan, Fariba verfasserin aut Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial 2019 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Melatonin may benefit diabetic people with coronary heart disease (CHD) through its beneficial effects on biomarkers of oxidative stress and cardio-metabolic risk. This investigation evaluated the effects of melatonin administration on metabolic status in diabetic patients with CHD. Oxidative stress Elsevier Melatonin supplementation Elsevier Metabolic status Elsevier Inflammation Elsevier Type 2 diabetes mellitus Elsevier Coronary heart disease Elsevier Ostadmohammadi, Vahidreza oth Bahmani, Fereshteh oth Reiter, Russel J. oth Asemi, Zatollah oth Enthalten in Elsevier Vinogradov, S. ELSEVIER Tip Avalanche Photodiode—A spherical-junction SiPM concept 2022 the official journal of the European Society of Parenteral & Enteral Nutrition Amsterdam [u.a.] (DE-627)ELV008775001 volume:38 year:2019 number:1 pages:191-196 extent:6 https://doi.org/10.1016/j.clnu.2017.12.004 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 33.05 Experimentalphysik VZ 33.07 Spektroskopie VZ 33.40 Kernphysik VZ AR 38 2019 1 191-196 6 |
language |
English |
source |
Enthalten in Tip Avalanche Photodiode—A spherical-junction SiPM concept Amsterdam [u.a.] volume:38 year:2019 number:1 pages:191-196 extent:6 |
sourceStr |
Enthalten in Tip Avalanche Photodiode—A spherical-junction SiPM concept Amsterdam [u.a.] volume:38 year:2019 number:1 pages:191-196 extent:6 |
format_phy_str_mv |
Article |
bklname |
Experimentalphysik Spektroskopie Kernphysik |
institution |
findex.gbv.de |
topic_facet |
Oxidative stress Melatonin supplementation Metabolic status Inflammation Type 2 diabetes mellitus Coronary heart disease |
dewey-raw |
530 |
isfreeaccess_bool |
false |
container_title |
Tip Avalanche Photodiode—A spherical-junction SiPM concept |
authorswithroles_txt_mv |
Raygan, Fariba @@aut@@ Ostadmohammadi, Vahidreza @@oth@@ Bahmani, Fereshteh @@oth@@ Reiter, Russel J. @@oth@@ Asemi, Zatollah @@oth@@ |
publishDateDaySort_date |
2019-01-01T00:00:00Z |
hierarchy_top_id |
ELV008775001 |
dewey-sort |
3530 |
id |
ELV045705380 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV045705380</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624115848.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191021s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.clnu.2017.12.004</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000523.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV045705380</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0261-5614(17)31424-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">530</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.05</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.07</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Raygan, Fariba</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Melatonin may benefit diabetic people with coronary heart disease (CHD) through its beneficial effects on biomarkers of oxidative stress and cardio-metabolic risk. This investigation evaluated the effects of melatonin administration on metabolic status in diabetic patients with CHD.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Oxidative stress</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Melatonin supplementation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Metabolic status</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Inflammation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Type 2 diabetes mellitus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Coronary heart disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ostadmohammadi, Vahidreza</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bahmani, Fereshteh</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Reiter, Russel J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Asemi, Zatollah</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Vinogradov, S. ELSEVIER</subfield><subfield code="t">Tip Avalanche Photodiode—A spherical-junction SiPM concept</subfield><subfield code="d">2022</subfield><subfield code="d">the official journal of the European Society of Parenteral & Enteral Nutrition</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV008775001</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:38</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:191-196</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.clnu.2017.12.004</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.05</subfield><subfield code="j">Experimentalphysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.07</subfield><subfield code="j">Spektroskopie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.40</subfield><subfield code="j">Kernphysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">38</subfield><subfield code="j">2019</subfield><subfield code="e">1</subfield><subfield code="h">191-196</subfield><subfield code="g">6</subfield></datafield></record></collection>
|
author |
Raygan, Fariba |
spellingShingle |
Raygan, Fariba ddc 530 bkl 33.05 bkl 33.07 bkl 33.40 Elsevier Oxidative stress Elsevier Melatonin supplementation Elsevier Metabolic status Elsevier Inflammation Elsevier Type 2 diabetes mellitus Elsevier Coronary heart disease Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
authorStr |
Raygan, Fariba |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV008775001 |
format |
electronic Article |
dewey-ones |
530 - Physics |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
530 VZ 33.05 bkl 33.07 bkl 33.40 bkl Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial Oxidative stress Elsevier Melatonin supplementation Elsevier Metabolic status Elsevier Inflammation Elsevier Type 2 diabetes mellitus Elsevier Coronary heart disease Elsevier |
topic |
ddc 530 bkl 33.05 bkl 33.07 bkl 33.40 Elsevier Oxidative stress Elsevier Melatonin supplementation Elsevier Metabolic status Elsevier Inflammation Elsevier Type 2 diabetes mellitus Elsevier Coronary heart disease |
topic_unstemmed |
ddc 530 bkl 33.05 bkl 33.07 bkl 33.40 Elsevier Oxidative stress Elsevier Melatonin supplementation Elsevier Metabolic status Elsevier Inflammation Elsevier Type 2 diabetes mellitus Elsevier Coronary heart disease |
topic_browse |
ddc 530 bkl 33.05 bkl 33.07 bkl 33.40 Elsevier Oxidative stress Elsevier Melatonin supplementation Elsevier Metabolic status Elsevier Inflammation Elsevier Type 2 diabetes mellitus Elsevier Coronary heart disease |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
v o vo f b fb r j r rj rjr z a za |
hierarchy_parent_title |
Tip Avalanche Photodiode—A spherical-junction SiPM concept |
hierarchy_parent_id |
ELV008775001 |
dewey-tens |
530 - Physics |
hierarchy_top_title |
Tip Avalanche Photodiode—A spherical-junction SiPM concept |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV008775001 |
title |
Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
ctrlnum |
(DE-627)ELV045705380 (ELSEVIER)S0261-5614(17)31424-3 |
title_full |
Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
author_sort |
Raygan, Fariba |
journal |
Tip Avalanche Photodiode—A spherical-junction SiPM concept |
journalStr |
Tip Avalanche Photodiode—A spherical-junction SiPM concept |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
500 - Science |
recordtype |
marc |
publishDateSort |
2019 |
contenttype_str_mv |
zzz |
container_start_page |
191 |
author_browse |
Raygan, Fariba |
container_volume |
38 |
physical |
6 |
class |
530 VZ 33.05 bkl 33.07 bkl 33.40 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Raygan, Fariba |
doi_str_mv |
10.1016/j.clnu.2017.12.004 |
dewey-full |
530 |
title_sort |
melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial |
title_auth |
Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
abstract |
Melatonin may benefit diabetic people with coronary heart disease (CHD) through its beneficial effects on biomarkers of oxidative stress and cardio-metabolic risk. This investigation evaluated the effects of melatonin administration on metabolic status in diabetic patients with CHD. |
abstractGer |
Melatonin may benefit diabetic people with coronary heart disease (CHD) through its beneficial effects on biomarkers of oxidative stress and cardio-metabolic risk. This investigation evaluated the effects of melatonin administration on metabolic status in diabetic patients with CHD. |
abstract_unstemmed |
Melatonin may benefit diabetic people with coronary heart disease (CHD) through its beneficial effects on biomarkers of oxidative stress and cardio-metabolic risk. This investigation evaluated the effects of melatonin administration on metabolic status in diabetic patients with CHD. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
container_issue |
1 |
title_short |
Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
url |
https://doi.org/10.1016/j.clnu.2017.12.004 |
remote_bool |
true |
author2 |
Ostadmohammadi, Vahidreza Bahmani, Fereshteh Reiter, Russel J. Asemi, Zatollah |
author2Str |
Ostadmohammadi, Vahidreza Bahmani, Fereshteh Reiter, Russel J. Asemi, Zatollah |
ppnlink |
ELV008775001 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth |
doi_str |
10.1016/j.clnu.2017.12.004 |
up_date |
2024-07-06T18:16:15.164Z |
_version_ |
1803854571283415040 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV045705380</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624115848.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191021s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.clnu.2017.12.004</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000523.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV045705380</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0261-5614(17)31424-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">530</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.05</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.07</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Raygan, Fariba</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Melatonin may benefit diabetic people with coronary heart disease (CHD) through its beneficial effects on biomarkers of oxidative stress and cardio-metabolic risk. This investigation evaluated the effects of melatonin administration on metabolic status in diabetic patients with CHD.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Oxidative stress</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Melatonin supplementation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Metabolic status</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Inflammation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Type 2 diabetes mellitus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Coronary heart disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ostadmohammadi, Vahidreza</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bahmani, Fereshteh</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Reiter, Russel J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Asemi, Zatollah</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Vinogradov, S. ELSEVIER</subfield><subfield code="t">Tip Avalanche Photodiode—A spherical-junction SiPM concept</subfield><subfield code="d">2022</subfield><subfield code="d">the official journal of the European Society of Parenteral & Enteral Nutrition</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV008775001</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:38</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:191-196</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.clnu.2017.12.004</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.05</subfield><subfield code="j">Experimentalphysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.07</subfield><subfield code="j">Spektroskopie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.40</subfield><subfield code="j">Kernphysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">38</subfield><subfield code="j">2019</subfield><subfield code="e">1</subfield><subfield code="h">191-196</subfield><subfield code="g">6</subfield></datafield></record></collection>
|
score |
7.401248 |